Skip to main content
. 2023 Jan 7;17:123–134. doi: 10.2147/OPTH.S399044

Table 3.

Comparison of Outcomes in Group B Before and After Screen-Time Reduction

Parameters Before (Mean ± SD)
Median (Range)
After (Mean ± SD)
Median (Range)
Mean Difference (After-Before) (95% Confidence of Interval) P value
Daily screen-hours (hours): 5.48±1.92 1±0 −4.48 (−5.27:-3.69) <0.0001
5 (3:9) 1 (1:1)
Visual outcomes (logMAR):
UDVA 0.36±0.25 0.23±0.22 −0.12 (−0.15:-0.10) <0.0001
0.3 (0:0.9) 0.2 (−0.2:0.7)
CDVA 0.02±0.08 −0.04±0.06 −0.06 (−0.10:-0.03) 0.002
0 (−0.1:0.2) 0 (−0.2:0)
mfERG examination outcomes:
I- Amplitudes P1:
(normal range nV/deg2)
Ring 1 54.00±10.86 70.50±12.30 16.50 (12.38:20.61) <0.0001
R1 (66.6–130.8) 49.75 (41.72:89.14) 67.37 (45.43:100.1)
Ring 2 30.99±5.02 37.92±7.16 6.93 (4.69:9.17) <0.0001
R2 (30.9–77.8) 31.8 (20.15:38.69) 36.45 (27.36:52.96)
Ring 3 20.22±3.45 24.18±4.46 3.96 (1.94:5.98) 0.0005
R3 (21.7–59) 20.32 (13.48:28.63) 23.69 (16.33:33.4)
Ring 4 12.11±2.60 12.28±2.36 0.17 (−0.49:0.83) 0.59
R4 (12.9–37.1) 11.85 (5.1:17.83) 12.22 (8.34:19.03)
Ring 5 8.63±1.92 9.21±2.05 0.57 (0.11:1.04) 0.02
R5 (10–28.2) 8.18 (4.32:12.62) 8.68 (6.7:14.95)
II- Amplitudes P1:
(normal range nV/deg2)
Quadrant 1 10.10±2.26 12.46±3.17 2.36 (1.43:3.30) <0.0001
Q1 (15.8–42.74) 10.1 (5.05:14.16) 11.89 (5.67:21.79)
Quadrant 2 13.31±2.70 13.72±2.79 0.41 (−0.33:1.16) 0.27
Q2 (15.98–42.75) 13.21 (6.44:20.18) 13.67 (8.56:19.41)
Quadrant 3 14.40±3.17 15.69±3.57 1.29 (0.01:2.57) 0.04
Q3 (15.18–42.05) 13.85 (4.89:19.43) 15.34 (8.45:22.41)
Quadrant 4 9.79±2.50 10.16±2.52 0.37 (−0.07:0.81) 0.10
Q4 (13.87–39.61) 10.59 (3.26:13.45) 9.87 (6.36:14.62)

Abbreviations: UDVA, uncorrected visual acuity; CDVA, uncorrected visual acuity; logMAR, logarithm of minimal angle of resolution; Amplitudes P1, amplitude density of the first foveal peak; deg, degree; nV, nanovolts; R1 to R5, Ring 1 to Ring 5; Q1 to Q4, Quadrant 1 to Quadrant 4; SD, standard deviation.